 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C18H25FN4O2 |
| Molar mass | 348.422 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5F-AB-PINACA is anindazole-basedsynthetic cannabinoid that is derived from a series of compounds originally developed byPfizer in 2009 as ananalgesic medication, and has been sold online as adesigner drug.[1][2]
5F-AB-PINACA has been reported to be a potentagonist of theCB1 receptor andCB2 receptor withEC50 values of 0.48 nM and 2.6 nM respectively.[3] Its metabolism has been described in literature.[4][5]
As of October 2015 5F-AB-PINACA is a controlled substance in China.[6]
5F-AB-PINACA is anAnlage II controlled substance in Germany as of May 2015.[7]
It is also controlled under the Fifth Schedule of the Misuse of Drugs Act (MDA) in Singapore as of May 2015.[8]
